FindTrial
Sign In

A study comparing how sugammadex and neostigmine work to reverse anesthesia in patients having chest surgery

Sugammadex Vs Neostigmine As A Reversal Agent In Patient Undergoing Thoracic Surgery Prospective randomized Observational Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078115
Enrollment
30
Registered
2024-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Inj.Sugammadex 4mg/kg at the end of surgery before extubation: Dosage : 4mg/kg body weight Route : Intravenous Duration : over 5seconds Control Intervention1: Injection Neostigmine 0.0

Sponsors

D Y Patil School Of Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Elective thoracic surgeries Patients between 18years to 60years Patients giving consent for study

Exclusion criteria

Exclusion criteria: Patients with severe hepatic, renal, endocrine and cardiac dysfunction Pregnant and lactating patients Patient not willing to participate in study

Design outcomes

Primary

MeasureTime frame
To assess the effective reversal of neuromuscular blockade in thoracic surgery using sugammadex in comparison to neostigmineTimepoint: At start of reversal , 2 mins , 4 mins , 6 mins , 8 mins, 10 mins , 1 hour , 6 hours post extubation—

Secondary

MeasureTime frame
To assess haemodynamic changes and residual muscle weaknessTimepoint: At start of reversal , 2 mins , 4 mins , 6 mins , 8 mins, 10 mins , 1 hour , 6 hours post extubation—

Countries

India

Contacts

Public ContactDr Manjula Sarkar

D Y Patil School Of Medicine

drmanjusarkar@gmail.com9869984017

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026